| Abilify MyCite (aripiprazole tablets embedded with sensor) / Otsuka |
OSMITTER, NCT02091882: Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) |
|
|
| Completed | 4 | 30 | US | Placebo, Combination product of Aripiprazole + IEM + Sensor + MIND1 Application, Abilify MyCite® | Otsuka Pharmaceutical Development & Commercialization, Inc. | Device Latency | 04/14 | 04/14 | | |
NCT03643159: A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder |
|
|
| Terminated | 4 | 2 | US | Abilify MyCite - Digital Medicine System, Aripiprazole or other oral antipsychotics | Otsuka Pharmaceutical Development & Commercialization, Inc. | Schizophrenia, Bipolar 1 Disorder, Major Depressive Disorder | 10/18 | 10/18 | | |
| Not yet recruiting | 4 | 60 | Europe | DM-Aripiprazole, DM-Olanzapine, DM- Quetiapine, DM-Risperidone, Tablet, Aripiprazole, Olanzapine, Quetiapine, Risperidone | Otsuka Pharmaceutical, Otsuka Pharmaceutical | Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT03568500: A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic |
|
|
| Completed | 4 | 44 | Europe | Digital Medicine System, Aripiprazole, Olanzapine, Quetiapine, Risperidone | Otsuka Pharmaceutical Development & Commercialization, Inc. | Schizophrenia, Schizoaffective Disorder, First Episode Psychosis | 05/19 | 09/19 | | |
DIMES, NCT03881449: - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole |
|
|
| Unknown status | 4 | 46 | US | ABILIFY MYCITE | Durham VA Medical Center, Otsuka Pharmaceutical Development and Commercialization, Inc. | Schizophrenia, Major Depressive Disorder, Bi-Polar Disorder, Schizo Affective Disorder | 01/21 | 11/21 | | |
